Welgene Biotech Co.,Ltd.
6661
Rank in Stocks
#28332
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis... Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
Share Price
$0.48775134
Last synced: 2026-11-09
Market Cap
$11.37M
Change (1 day)
0.05%
Change (1 year)
-17.84%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Welgene Biotech Co.,Ltd. (6661)
Category
Healthcare
Operating Margin for Welgene Biotech Co.,Ltd. (6661)
Operating Margin as of November 2026 TTM: -0.62%
According to Welgene Biotech Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is -0.62%. At the end of 2025 the company had an operating margin of 0.03%.
Operating Margin history for Welgene Biotech Co.,Ltd. from 2014 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -0.62% | -2,166.67% |
| 2025 | 0.03% | -113.64% |
| 2024 | -0.22% | -85.53% |
| 2023 | -1.52% | -129.46% |
| 2022 | 5.16% | 32.65% |
| 2021 | 3.89% | -59.98% |
| 2020 | 9.72% | -1.02% |
| 2019 | 9.82% | -1.41% |
| 2018 | 9.96% | 17.73% |
| 2017 | 8.46% | 169.43% |
| 2016 | 3.14% | -64.56% |
| 2015 | 8.86% | -29.35% |
| 2014 | 12.54% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -129.00% |
US
|
|
| 20.38% | -132.87% |
US
|
|
| 43.02% | -169.39% |
CN
|
|
| 32.03% | -151.66% |
US
|
|
| 22.23% | -135.85% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Welgene Biotech Co.,Ltd.'s operating margin
What is Welgene Biotech Co.,Ltd.'s operating margin?
Welgene Biotech Co.,Ltd.'s operating margin is -0.62%, as of Nov 2026.
What was Welgene Biotech Co.,Ltd.'s operating margin in 2025?
In 2025, Welgene Biotech Co.,Ltd.'s operating margin was 0.03%, compared with -0.22% in 2024.
How has Welgene Biotech Co.,Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Welgene Biotech Co.,Ltd.'s operating margin was highest in 2020 (9.72%) and lowest in 2023 (-1.52%).
How does Welgene Biotech Co.,Ltd.'s operating margin compare with similar companies?
Welgene Biotech Co.,Ltd.'s operating margin (-0.62%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.